- Home
- GTLB vs LEGN Comparison
GTLB vs LEGN Comparison
Compare GTLB & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTLB
- LEGN
- Stock Information
- Founded
- GTLB 2011
- LEGN 2014
- Country
- GTLB United States
- LEGN United States
- Employees
- GTLB N/A
- LEGN N/A
- Industry
- GTLB EDP Services
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- GTLB Technology
- LEGN Health Care
- Exchange
- GTLB Nasdaq
- LEGN Nasdaq
- Market Cap
- GTLB 7.0B
- LEGN 7.0B
- IPO Year
- GTLB 2021
- LEGN 2020
- Fundamental
- Price
- GTLB $53.43
- LEGN $27.80
- Analyst Decision
- GTLB Strong Buy
- LEGN Strong Buy
- Analyst Count
- GTLB 23
- LEGN 13
- Target Price
- GTLB $71.22
- LEGN $75.67
- AVG Volume (30 Days)
- GTLB 2.2M
- LEGN 1.6M
- Earning Date
- GTLB 06-02-2025
- LEGN 05-13-2025
- Dividend Yield
- GTLB N/A
- LEGN N/A
- EPS Growth
- GTLB N/A
- LEGN N/A
- EPS
- GTLB N/A
- LEGN N/A
- Revenue
- GTLB $759,249,000.00
- LEGN $728,303,000.00
- Revenue This Year
- GTLB $26.19
- LEGN $65.96
- Revenue Next Year
- GTLB $21.91
- LEGN $52.55
- P/E Ratio
- GTLB N/A
- LEGN N/A
- Revenue Growth
- GTLB 30.93
- LEGN 112.46
- 52 Week Low
- GTLB $37.90
- LEGN $29.27
- 52 Week High
- GTLB $74.18
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- GTLB 66.04
- LEGN 29.31
- Support Level
- GTLB $44.53
- LEGN $30.25
- Resistance Level
- GTLB $47.41
- LEGN $33.30
- Average True Range (ATR)
- GTLB 1.74
- LEGN 1.72
- MACD
- GTLB 1.16
- LEGN -0.41
- Stochastic Oscillator
- GTLB 93.59
- LEGN 3.14
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.